Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 707

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases

Open access
Chin-Chan, Miguel, Navarro-Yepes, Juliana, Quintanilla-Vega, Betzabet·2015·Frontiers in Cellular Neuroscience
DOI 10.3389/fncel.2015.00124
Open this paper in CoChat — free account

Abstract

Neurodegenerative diseases including Alzheimer (AD) and Parkinson (PD) have attracted attention in last decades due to their high incidence worldwide. The etiology of these diseases is still unclear; however the role of the environment as a putative risk factor has gained importance. More worryingly is the evidence that pre- and post-natal exposures to environmental factors predispose to the onset of neurodegenerative diseases in later life. Neurotoxic metals such as lead, mercury, aluminum, cadmium and arsenic, as well as some pesticides and metal-based nanoparticles have been involved in AD due to their ability to increase beta-amyloid (Aβ) peptide and the phosphorylation of Tau protein (P-Tau), causing senile/amyloid plaques and neurofibrillary tangles (NFTs) characteristic of AD. The exposure to lead, manganese, solvents and some pesticides has been related to hallmarks of PD such as mitochondrial dysfunction, alterations in metal homeostasis and aggregation of proteins such as α-synuclein (α-syn), which is a key constituent of Lewy bodies (LB), a crucial factor in PD pathogenesis. Common mechanisms of environmental pollutants to increase Aβ, P-Tau, α-syn and neuronal death have been reported, including the oxidative stress mainly involved in the increase of Aβ and α-syn, and the reduced activity/protein levels of Aβ degrading enzyme (IDE)s such as neprilysin or insulin IDE. In addition, epigenetic mechanisms by maternal nutrient supplementation and exposure to heavy metals and pesticides have been proposed to lead phenotypic diversity and susceptibility to neurodegenerative diseases. This review discusses data from epidemiological and experimental studies about the role of environmental factors in the development of idiopathic AD and PD, and their mechanisms of action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2015.00124

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 242

  1. Abbott, 2012, Late-life hemoglobin and the incidence of Parkinson’s disease, Neurobiol. Aging, 33, 914, 10.1016/j.neurobiolaging.2010.06.023 · DOI
  2. Altmann, 1999, Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident, BMJ, 319, 807, 10.1136/bmj.319.7213.807 · DOI
  3. Alvarez, 2013, Influence of gold nanoparticles on the kinetics of alpha-synuclein aggregation, Nano Lett., 13, 6156, 10.1021/nl403490e · DOI
  4. An, 2012, Cognitive impairment in rats induced by nano-CuO and its possible mechanisms, Toxicol. Lett., 213, 220, 10.1016/j.toxlet.2012.07.007 · DOI
  5. Ascherio, 2006, Pesticide exposure and risk for Parkinson’s disease, Ann. Neurol., 60, 197, 10.1002/ana.20904 · DOI · Paper page
  6. Ashok, 2015, Exposure to As-, Cd- and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats, Toxicol. Sci., 143, 64, 10.1093/toxsci/kfu208 · DOI · Paper page
  7. Baldi, 2003, Neurodegenerative diseases and exposure to pesticides in the elderly, Am. J. Epidemiol., 157, 409, 10.1093/aje/kwf216 · DOI · Paper page
  8. Barlow, 2004, A fetal risk factor for Parkinson’s disease, Dev. Neurosci., 26, 11, 10.1159/000080707 · DOI
  9. Basha, 2005, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J. Neurosci., 25, 823, 10.1523/jneurosci.4335-04.2005 · DOI · Paper page
  10. Basun, 1991, Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer’s disease, J. Neural Transm. Park. Dis. Dement. Sect., 3, 231
  11. Baum, 2010, Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability, Biometals, 23, 173, 10.1007/s10534-009-9277-5 · DOI
  12. Behl, 2009, Increased β-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1, Toxicol. Appl. Pharmacol., 240, 245, 10.1016/j.taap.2009.05.024 · DOI
  13. Behl, 2010, Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C, Neurotoxicology, 31, 524, 10.1016/j.neuro.2010.05.004 · DOI
  14. Bergen, 1971, The in vitro effect of dieldrin on respiration of rat liver mitochondria, Proc. Soc. Exp. Biol. Med., 136, 732, 10.3181/00379727-136-35352 · doi:10.3181/00379727-136-35352
  15. Berry, 2010, Paraquat and Parkinson’s disease, Cell Death Differ., 17, 1115, 10.1038/cdd.2009.217 · DOI · Paper page
  16. Betarbet, 2006, Intersecting pathways to neurodegeneration in Parkinson’s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein and the ubiquitin-proteasome system, Neurobiol. Dis., 22, 404, 10.1016/j.nbd.2005.12.003 · DOI · Paper page
  17. Betarbet, 2000, Chronic systemic pesticide exposure reproduces features of Parkinson’s disease, Nat. Neurosci., 3, 1301, 10.1038/81834 · DOI · Paper page
  18. Bhatt, 1999, Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases, Neurology, 52, 1467, 10.1212/wnl.52.7.1467 · DOI
  19. Bhattacharjee, 2014, Aluminum and its potential contribution to Alzheimer’s disease (AD), Front. Aging Neurosci., 6, 62, 10.3389/fnagi.2014.00062 · DOI
  20. Bihaqi, 2012, Alzheimer’s disease biomarkers and epigenetic intermediates following exposure to Pb in vitro, Curr. Alzheimer Res., 9, 555, 10.2174/156720512800617964 · DOI
  21. Bihaqi, 2013, Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb), Neurotoxicology, 39, 95, 10.1016/j.neuro.2013.07.010 · DOI
  22. Botta-Orfila, 2014, Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson’s disease, J. Neurosci. Res., 92, 1071, 10.1002/jnr.23377 · DOI
  23. Brooks, 1999, Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss, Brain Res., 823, 1, 10.1016/s0006-8993(98)01192-5 · DOI · Paper page
  24. Brown, 2006, Pesticides and Parkinson’s disease–is there a link?, Environ. Health Perspect., 114, 156, 10.1289/ehp.8095 · DOI · Paper page
  25. Butterfield, 2001, Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid β-peptide, Trends Mol. Med., 7, 548, 10.1016/s1471-4914(01)02173-6 · DOI · Paper page
  26. Buzea, 2007, Nanomaterials and nanoparticles: sources and toxicity, Biointerphases, 2, MR17, 10.1116/1.2815690 · DOI · Paper page
  27. Cannon, 2009, A highly reproducible rotenone model of Parkinson’s disease, Neurobiol. Dis., 34, 279, 10.1016/j.nbd.2009.01.016 · DOI · Paper page
  28. Castello, 2007, Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain, J. Biol. Chem., 282, 14186, 10.1074/jbc.m700827200 · DOI · Paper page
  29. Chang, 2008, Cognitive function and blood methylmercury in adults living near a deserted chloralkali factory, Environ. Res., 108, 334, 10.1016/j.envres.2008.06.006 · DOI
  30. Chen, 2012b, Pesticides induce spatial memory deficits with synaptic impairments and an imbalanced tau phosphorylation in rats, J. Alzheimers Dis., 30, 585, 10.3233/JAD-2012-111946 · DOI
  31. Chen, 2012a, Cognitive impairment and increased Aβ levels induced by paraquat exposure are attenuated by enhanced removal of mitochondrial H2O2, Neurobiol. Aging, 33, 432.e15, 10.1016/j.neurobiolaging.2011.01.008 · DOI
  32. Chiba-Falek, 2006, Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients, Mov. Disord., 21, 1703, 10.1002/mds.21007 · DOI
  33. Chin-Chan, 2015, Mercury reduces the enzymatic activity of neprilysin in differentiated SH-SY5Y cells, Toxicol. Sci., 10.1093/toxsci/kfv037 · DOI
  34. Clayton, 2005, Cytochrome c release from rat brain mitochondria is proportional to the mitochondrial functional deficit: implications for apoptosis and neurodegenerative disease, J. Neurochem., 92, 840, 10.1111/j.1471-4159.2004.02918.x · DOI
  35. Cook, 1974, Chronic manganese intoxication, Arch. Neurol., 30, 59, 10.1001/archneur.1974.00490310061010 · DOI
  36. Coon, 2006, Whole-body lifetime occupational lead exposure and risk of Parkinson’s disease, Environ. Health Perspect., 114, 1872, 10.1289/ehp.9102 · DOI · Paper page
  37. Corrigan, 1998, Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson’s disease, Exp. Neurol., 150, 339, 10.1006/exnr.1998.6776 · DOI · Paper page
  38. Corrigan, 2000, Organochlorine insecticides in substantia nigra in Parkinson’s disease, J. Toxicol. Environ. Health A, 59, 229, 10.1080/009841000156907 · DOI · Paper page
  39. Corti, 2011, What genetics tells us about the causes and mechanisms of Parkinson’s disease, Physiol. Rev., 91, 1161, 10.1152/physrev.00022.2010 · DOI · Paper page
  40. Couper, 1837, On the effects of black oxide of manganese when inhaled into the lungs, Br. Ann. Med. Pharmacol., 1, 41
  41. Cras, 1990, Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer’s disease, Am. J. Pathol., 137, 241
  42. Dani, 2010, Arsenic for the fool: an exponential connection, Sci. Total Environ., 408, 1842, 10.1016/j.scitotenv.2010.01.027 · DOI
  43. Desplats, 2011, Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases, J. Biol. Chem., 286, 9031, 10.1074/jbc.C110.212589 · DOI · Paper page
  44. Dexter, 1987, Increased nigral iron content in postmortem parkinsonian brain, Lancet, 2, 1219, 10.1016/s0140-6736(87)91361-4 · DOI · Paper page
  45. Dhillon, 2008, Pesticide/environmental exposures and Parkinson’s disease in east texas, J. Agromedicine, 13, 37, 10.1080/10599240801986215 · DOI
  46. Ding, 2001, Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins, J. Neurochem., 77, 1010, 10.1046/j.1471-4159.2001.00302.x · DOI · Paper page
  47. Dorsey, 2006, Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores, J. Occup. Environ. Med., 48, 489, 10.1097/01.jom.0000199678.86629.3b · DOI
  48. Drechsel, 2009, Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism, Toxicol. Sci., 112, 427, 10.1093/toxsci/kfp223 · DOI
  49. Duan, 2002, Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease, J. Neurochem., 80, 101, 10.1046/j.0022-3042.2001.00676.x · DOI · Paper page
  50. Etminan, 2003, Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer’s disease: systematic review and meta-analysis of observational studies, BMJ, 327, 128, 10.1136/bmj.327.7407.128 · DOI · Paper page
  51. Exley, 2006, Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK, J. Neurol. Neurosurg. Psychiatry, 77, 877, 10.1136/jnnp.2005.086553 · DOI
  52. Exley, 1993, An interaction of beta-amyloid with aluminium in vitro, FEBS Lett., 324, 293, 10.1016/0014-5793(93)80137-j · DOI · Paper page
  53. Fei, 2008, Paraquat neurotoxicity is mediated by a Bak-dependent mechanism, J. Biol. Chem., 283, 3357, 10.1074/jbc.m708451200 · DOI
  54. Firestone, 2005, Pesticides and risk of Parkinson disease: a population-based case-control study, Arch. Neurol., 62, 91, 10.1001/archneur.62.1.91 · DOI
  55. Fleming, 1994, Parkinson’s disease and brain levels of organochlorine pesticides, Ann. Neurol., 36, 100, 10.1002/ana.410360119 · DOI · Paper page
  56. Franco, 2010, Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson’s disease, Chem. Biol. Interact., 188, 289, 10.1016/j.cbi.2010.06.003 · DOI · Paper page
  57. Freire, 2012, Pesticide exposure and Parkinson’s disease: epidemiological evidence of association, Neurotoxicology, 33, 947, 10.1016/j.neuro.2012.05.011 · DOI · Paper page
  58. Friedhoff, 2000, Structure of tau protein and assembly into paired helical filaments, Biochim. Biophys. Acta, 1502, 122, 10.1016/S0925-4439(00)00038-7 · DOI
  59. Fujimura, 2009, Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain, Neurotoxicology, 30, 1000, 10.1016/j.neuro.2009.08.001 · DOI
  60. Gao, 2011, Gene-environment interactions: key to unraveling the mystery of Parkinson’s disease, Prog. Neurobiol., 94, 1, 10.1016/j.pneurobio.2011.03.005 · DOI · Paper page
  61. Gao, 2002, Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons, J. Neurosci., 22, 782, 10.1523/JNEUROSCI.22-03-00782.2002 · DOI · Paper page
  62. Gash, 2008, Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity, Ann. Neurol., 63, 184, 10.1002/ana.21288 · DOI · Paper page
  63. Gatto, 2009, Well-water consumption and Parkinson’s disease in rural California, Environ. Health Perspect., 117, 1912, 10.1289/ehp.0900852 · DOI
  64. Gerhardsson, 2008, Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer’s disease, Dement. Geriatr. Cogn. Disord., 25, 508, 10.1159/000129365 · DOI · Paper page
  65. Godfrey, 2003, Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity, J. Alzheimers Dis., 5, 189, 10.3233/JAD-2003-5303 · DOI
  66. Goedert, 2006, A century of Alzheimer’s disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
  67. Goldman, 2014, Environmental toxins and Parkinson’s disease, Annu. Rev. Pharmacol. Toxicol., 54, 141, 10.1146/annurev-pharmtox-011613-135937 · DOI · Paper page
  68. Goldman, 2012, Solvent exposures and Parkinson disease risk in twins, Ann. Neurol., 71, 776, 10.1002/ana.22629 · DOI · Paper page
  69. Gong, 2010, The arsenic exposure hypothesis for Alzheimer disease, Alzheimer Dis. Assoc. Disord., 24, 311, 10.1097/WAD.0b013e3181d71bc7 · DOI
  70. González-Polo, 2004, Paraquat-induced apoptotic cell death in cerebellar granule cells, Brain Res., 1011, 170, 10.1016/s0006-8993(04)00466-4 · doi:10.1016/s0006-8993(04)00466-4
  71. Goodall, 2013, Neuronal dark matter: the emerging role of microRNAs in neurodegeneration, Front. Cell. Neurosci., 7, 178, 10.3389/fncel.2013.00178 · DOI · Paper page
  72. Gorell, 2004, Multiple risk factors for Parkinson’s disease, J. Neurol. Sci., 217, 169, 10.1016/j.jns.2003.09.014 · DOI
  73. Götz, 2001, Tau and transgenic animal models, Brain Res. Brain Res. Rev., 35, 266, 10.1016/s0165-0173(01)00055-8 · DOI
  74. Greenblatt, 1994, Folic acid in neurodevelopment and child psychiatry, Prog. Neuropsychopharmacol. Biol. Psychiatry, 18, 647, 10.1016/0278-5846(94)90074-4 · DOI
  75. Gu, 2011, Lead exposure increases levels of beta-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice, Neurosci. Lett., 490, 16, 10.1016/j.neulet.2010.12.017 · DOI
  76. Guilarte, 2013, Manganese neurotoxicity: new perspectives from behavioral, neuroimaging and neuropathological studies in humans and non-human primates, Front. Aging Neurosci., 5, 23, 10.3389/fnagi.2013.00023 · DOI
  77. Halliwell, 1992, Free radicals, antioxidants and human disease: where are we now?, J. Lab. Clin. Med., 119, 598
  78. Harischandra, 2015, α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease, Toxicol. Sci., 143, 454, 10.1093/toxsci/kfu247 · doi:10.1093/toxsci/kfu247
  79. Hatcher, 2008, Parkinson’s disease and pesticides: a toxicological perspective, Trends Pharmacol. Sci., 29, 322, 10.1016/j.tips.2008.03.007 · DOI · Paper page
  80. Hatcher, 2007, Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system, Exp. Neurol., 204, 619, 10.1016/j.expneurol.2006.12.020 · DOI
  81. Hayden, 2010, Occupational exposure to pesticides increases the risk of incident AD: the Cache County study, Neurology, 74, 1524, 10.1212/WNL.0b013e3181dd4423 · DOI · Paper page
  82. Hernandez, 2014, Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice, Nanomedicine, 10, 745, 10.1016/j.nano.2013.11.013 · DOI
  83. Hertzman, 1990, Parkinson’s disease: a case-control study of occupational and environmental risk factors, Am. J. Ind. Med., 17, 349, 10.1002/ajim.4700170307 · DOI · Paper page
  84. Hirsch, 1991, Iron and aluminum increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis, J. Neurochem., 56, 446, 10.1111/j.1471-4159.1991.tb08170.x · DOI · Paper page
  85. Hock, 1998, Increased blood mercury levels in patients with Alzheimer’s disease, J. Neural Transm., 105, 59, 10.1007/s007020050038 · DOI
  86. Holliday, 2006, Epigenetics: a historical overview, Epigenetics, 1, 76, 10.4161/epi.1.2.2762 · DOI · Paper page
  87. Huang, 2011, In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AbetaPP and neprilysin, Neurotoxicology, 32, 300, 10.1016/j.neuro.2011.02.001 · DOI
  88. Huang, 2015, Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells, Environ. Res., 136, 253, 10.1016/j.envres.2014.11.006 · DOI
  89. Huang, 1993, Progression after chronic manganese exposure, Neurology, 43, 1479, 10.1212/WNL.43.8.1479 · DOI · Paper page
  90. Iwata, 2014, Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation, Hum. Mol. Genet., 23, 648, 10.1093/hmg/ddt451 · DOI
  91. Jang, 2014, Nutrition, epigenetics and diseases, Clin. Nutr. Res., 3, 1, 10.7762/cnr.2014.3.1.1 · DOI
  92. Jankovic, 2005, Searching for a relationship between manganese and welding and Parkinson’s disease, Neurology, 64, 2021, 10.1212/01.wnl.0000166916.40902.63 · DOI
  93. Jiang, 2007, Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer’s tau fragment corresponding to the third repeat of microtubule-binding domain, Biochim. Biophys. Acta, 1774, 1414, 10.1016/j.bbapap.2007.08.014 · DOI
  94. Johansson, 2007, Neurobehavioural and molecular changes induced by methylmercury exposure during development, Neurotox. Res., 11, 241, 10.1007/bf03033570 · DOI
  95. Jowaed, 2010, Methylation regulates alpha-synuclein expression and is decreased in Parkinson’s disease patients’ brains, J. Neurosci., 30, 6355, 10.1523/jneurosci.6119-09.2010 · DOI · Paper page
  96. Kala, 1995, Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study, J. Neurochem., 65, 1631, 10.1046/j.1471-4159.1995.65041631.x · doi:10.1046/j.1471-4159.1995.65041631.x
  97. Kamel, 2007, Pesticide exposure and self-reported Parkinson’s disease in the agricultural health study, Am. J. Epidemiol., 165, 364, 10.1093/aje/kwk024 · DOI · Paper page
  98. Kang, 2009, Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice, Toxicol. Lett., 188, 148, 10.1016/j.toxlet.2009.03.026 · DOI
  99. Kanthasamy, 2005, Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis, Neurotoxicology, 26, 701, 10.1016/j.neuro.2004.07.010 · DOI · Paper page
  100. Kaur, 2007, Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age, Neurobiol. Aging, 28, 907, 10.1016/j.neurobiolaging.2006.04.003 · DOI
  101. Kawahara, 2001, Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein, Brain Res. Bull., 55, 211, 10.1016/s0361-9230(01)00475-0 · DOI · Paper page
  102. Kim, 2014, Mercury-induced amyloid-beta (Aβ) accumulation in the brain is mediated by disruption of Aβ transport, J. Toxicol. Sci., 39, 625, 10.2131/jts.39.625 · DOI
  103. Kitazawa, 2001, Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells, Free Radic. Biol. Med., 31, 1473, 10.1016/s0891-5849(01)00726-2 · DOI
  104. Kitazawa, 2003, Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration, Neuroscience, 119, 945, 10.1016/s0306-4522(03)00226-4 · DOI
  105. Kochen, 2003, The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson’s disease, Adv. Exp. Med. Biol., 527, 253, 10.1007/978-1-4615-0135-0_29 · doi:10.1007/978-1-4615-0135-0_29
  106. Kojro, 2005, The non-amyloidogenic pathway: structure and function of alpha-secretases, Subcell Biochem., 38, 105, 10.1007/0-387-23226-5_5 · DOI
  107. Kuhn, 1998, High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries, Neurology, 50, 1885, 10.1212/wnl.50.6.1885 · DOI
  108. Kuter, 2010, Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues, Neurochem. Res., 35, 1121, 10.1007/s11064-010-0163-x · DOI
  109. Kwok, 2010, Role of epigenetics in Alzheimer’s and Parkinson’s disease, Epigenomics, 2, 671, 10.2217/epi.10.43 · DOI
  110. Lai, 2002, Occupational and environmental risk factors for Parkinson’s disease, Parkinsonism Relat. Disord., 8, 297, 10.1016/s1353-8020(01)00054-2 · DOI
  111. Langston, 1983, Parkinson’s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, N. Engl. J. Med., 309, 310, 10.1056/nejm198308043090511 · DOI · Paper page
  112. Langston, 1983, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 · DOI · Paper page
  113. Langston, 1984, Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey, Brain Res., 292, 390, 10.1016/0006-8993(84)90777-7 · DOI · Paper page
  114. Lee, 2000, Manganese intoxication, Arch. Neurol., 57, 597, 10.1001/archneur.57.4.597 · DOI
  115. Lewczuk, 2014, Biomarkers of Alzheimer’s disease and mild cognitive impairment: a current perspective, Adv. Med. Sci., 60, 76, 10.1016/j.advms.2014.11.002 · DOI
  116. Li, 2010b, Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells, Neurosci. Bull., 26, 205, 10.1007/s12264-010-1117-7 · DOI · Paper page
  117. Li, 2014b, SiO2 nanoparticles change colour preference and cause Parkinson’s-like behaviour in zebrafish, Sci. Rep., 4, 3810, 10.1038/srep03810 · DOI
  118. Li, 2014a, The effects of early life Pb exposure on the expression of IL1-beta, TNF-alpha and Abeta in cerebral cortex of mouse pups, J. Trace Elem. Med. Biol., 28, 100, 10.1016/j.jtemb.2013.07.003 · doi:10.1016/j.jtemb.2013.07.003
  119. Li, 2012, The effect of cadmium on Abeta levels in APP/PS1 transgenic mice, Exp. Ther. Med., 4, 125, 10.3892/etm.2012.562 · DOI
  120. Li, 2010a, Increased tau phosphorylation and beta amyloid in the hipocampus of mouse pups by early life lead exposure, Acta Biol. Hung., 61, 123, 10.1556/abiol.61.2010.2.1 · DOI
  121. Liou, 1997, Environmental risk factors and Parkinson’s disease: a case-control study in Taiwan, Neurology, 48, 1583, 10.1212/wnl.48.6.1583 · DOI · Paper page
  122. Liu, 2010, Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats, J. Neurochem., 112, 773, 10.1111/j.1471-4159.2009.06497.x · DOI
  123. Liu, 2013, Exposure to silver nanoparticles does not affect cognitive outcome or hippocampal neurogenesis in adult mice, Ecotoxicol. Environ. Saf., 87, 124, 10.1016/j.ecoenv.2012.10.014 · DOI
  124. Liu, 2014, Effects of lead exposure on the expression of amyloid beta and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages, J. Trace Elem. Med. Biol., 28, 227, 10.1016/j.jtemb.2014.01.002 · doi:10.1016/j.jtemb.2014.01.002
  125. Lock, 2013, Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence, Toxicol. Appl. Pharmacol., 266, 345, 10.1016/j.taap.2012.11.016 · DOI
  126. Logroscino, 2005, The role of early life environmental risk factors in Parkinson disease: what is the evidence?, Environ. Health Perspect., 113, 1234, 10.1289/ehp.7573 · DOI
  127. Logroscino, 2008, Dietary iron intake and risk of Parkinson’s disease, Am. J. Epidemiol., 168, 1381, 10.1093/aje/kwn273 · DOI · Paper page
  128. Lu, 1994, Levodopa failure in chronic manganism, Neurology, 44, 1600, 10.1212/wnl.44.9.1600 · doi:10.1212/wnl.44.9.1600
  129. Lu, 2013, DNA methylation, a hand behind neurodegenerative diseases, Front. Aging Neurosci., 5, 85, 10.3389/fnagi.2013.00085 · DOI
  130. Lui, 1990, Metals and the liver in Alzheimer’s disease. An investigation of hepatic zinc, copper, cadmium and metallothionein, J. Am. Geriatr. Soc., 38, 633, 10.1111/j.1532-5415.1990.tb01421.x · DOI
  131. Lukiw, 2012, NF-kappaB-regulated, proinflammatory miRNAs in Alzheimer’s disease, Alzheimers Res. Ther., 4, 47, 10.1186/alzrt150 · DOI
  132. Luo, 2009, Altered expression of Abeta metabolism-associated molecules from D-galactose/AlCl(3) induced mouse brain, Mech. Ageing Dev., 130, 248, 10.1016/j.mad.2008.12.005 · DOI
  133. Maciotta, 2013, The involvement of microRNAs in neurodegenerative diseases, Front. Cell. Neurosci., 7, 265, 10.3389/fncel.2013.00265 · DOI · Paper page
  134. Manning-Bog, 2002, The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein, J. Biol. Chem., 277, 1641, 10.1074/jbc.c100560200 · DOI · Paper page
  135. Mao, 2008, Synergistic microglial reactive oxygen species generation induced by pesticides lindane and dieldrin, Neuroreport, 19, 1317, 10.1097/wnr.0b013e32830b3677 · DOI
  136. Marques, 2011, Epigenetics in neurodegeneration: a new layer of complexity, Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 348, 10.1016/j.pnpbp.2010.08.008 · DOI
  137. Martínez, 2011, Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity, Neurochem. Int., 58, 574, 10.1016/j.neuint.2011.01.020 · DOI
  138. Mason, 2014, Pb neurotoxicity: neuropsychological effects of lead toxicity, Biomed. Res. Int., 2014, 840547, 10.1155/2014/840547 · DOI · Paper page
  139. Matsumoto, 2010, CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson’s disease, PLoS One, 5, e15522, 10.1371/journal.pone.0015522 · DOI · Paper page
  140. McCormack, 2005, Role of oxidative stress in paraquat-induced dopaminergic cell degeneration, J. Neurochem., 93, 1030, 10.1111/j.1471-4159.2005.03088.x · DOI · Paper page
  141. McCormack, 2002, Environmental risk factors and Parkinson’s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat, Neurobiol. Dis., 10, 119, 10.1006/nbdi.2002.0507 · DOI · Paper page
  142. McDonnell, 2003, Occupational exposure to solvents and metals and Parkinson’s disease, Neurology, 61, 716, 10.1212/wnl.61.5.716 · DOI
  143. McNaught, 2002, Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson’s disease, Neurosci. Lett., 326, 155, 10.1016/s0304-3940(02)00296-3 · DOI
  144. McNaught, 2001, Proteasomal function is impaired in substantia nigra in Parkinson’s disease, Neurosci. Lett., 297, 191, 10.1016/s0304-3940(00)01701-8 · DOI · Paper page
  145. Miñones-Moyano, 2011, MicroRNA profiling of Parkinson’s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function, Hum. Mol. Genet., 20, 3067, 10.1093/hmg/ddr210 · DOI · Paper page
  146. Miyake, 2011, Dietary intake of metals and risk of Parkinson’s disease: a case-control study in Japan, J. Neurol. Sci., 306, 98, 10.1016/j.jns.2011.03.035 · DOI
  147. Mogi, 1996, Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson’s disease, Neurosci. Lett., 211, 13, 10.1016/0304-3940(96)12706-3 · DOI · Paper page
  148. Monnet-Tschudi, 2006, Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases, Rev. Environ. Health, 21, 105, 10.1515/reveh.2006.21.2.105 · DOI · Paper page
  149. Mortimer, 2012, Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis, Neurology, 79, 1174, 10.1212/WNL.0b013e3182698ced · DOI
  150. Mutter, 2004, Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator, Neuro. Endocrinol. Lett., 25, 331
  151. Nalivaeva, 2012, Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?, J. Neurochem., 120, 167, 10.1111/j.1471-4159.2011.07510.x · DOI · Paper page
  152. Nasuti, 2013, Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats, Toxicology, 303, 162, 10.1016/j.tox.2012.09.016 · DOI
  153. Navarro-Yepes, 2014, Antioxidant gene therapy against neuronal cell death, Pharmacol. Ther., 142, 206, 10.1016/j.pharmthera.2013.12.007 · DOI · Paper page
  154. O’Bryant, 2011, Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study, Int. J. Environ. Res. Public Health, 8, 861, 10.3390/ijerph8030861 · DOI
  155. Olivieri, 2000, Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells, J. Neurochem., 74, 231, 10.1046/j.1471-4159.2000.0740231.x · DOI · Paper page
  156. Papageorgiou, 2009, Severe dopaminergic pathways damage in a case of chronic toluene abuse, Clin. Neurol. Neurosurg., 111, 864, 10.1016/j.clineuro.2009.07.007 · doi:10.1016/j.clineuro.2009.07.007
  157. Park, 2013, Neurobehavioral deficits and parkinsonism in occupations with manganese exposure: a review of methodological issues in the epidemiological literature, Saf. Health Work, 4, 123, 10.1016/j.shaw.2013.07.003 · DOI
  158. Park, 2014, Serum trace metal levels in Alzheimer’s disease and normal control groups, Am. J. Alzheimers Dis. Other Demen., 29, 76, 10.1177/1533317513506778 · DOI
  159. Peris-Sampedro, 2014, Impaired retention in AbetaPP Swedish mice six months after oral exposure to chlorpyrifos, Food Chem. Toxicol., 72, 289, 10.1016/j.fct.2014.07.036 · DOI
  160. Perl, 2007, The neuropathology of manganese-induced Parkinsonism, J. Neuropathol. Exp. Neurol., 66, 675, 10.1097/nen.0b013e31812503cf · DOI · Paper page
  161. Pezzoli, 1989, Parkinsonism due to n-hexane exposure, Lancet, 2, 874, 10.1016/s0140-6736(89)93050-x · doi:10.1016/s0140-6736(89)93050-x
  162. Pezzoli, 1990, n-hexane induces parkinsonism in rodents, Brain Res., 531, 355, 10.1016/0006-8993(90)90801-h · doi:10.1016/0006-8993(90)90801-h
  163. Pieper, 2008, Different methylation of the TNF-alpha promoter in cortex and substantia nigra: implications for selective neuronal vulnerability, Neurobiol. Dis., 32, 521, 10.1016/j.nbd.2008.09.010 · DOI
  164. Pisanic, 2007, Nanotoxicity of iron oxide nanoparticle internalization in growing neurons, Biomaterials, 28, 2572, 10.1016/j.biomaterials.2007.01.043 · DOI · Paper page
  165. Pogue, 2011, Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures, J. Inorg. Biochem., 105, 1434, 10.1016/j.jinorgbio.2011.05.012 · DOI
  166. Poirier, 2002, The prospective role of abnormal methyl metabolism in cadmium toxicity, Environ. Health Perspect., 110, 793, 10.1289/ehp.02110s5793 · DOI
  167. Priyadarshi, 2001, Environmental risk factors and Parkinson’s disease: a metaanalysis, Environ. Res., 86, 122, 10.1006/enrs.2001.4264 · DOI · Paper page
  168. Priyadarshi, 2000, A meta-analysis of Parkinson’s disease and exposure to pesticides, Neurotoxicology, 21, 435
  169. Purisai, 2007, Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration, Neurobiol. Dis., 25, 392, 10.1016/j.nbd.2006.10.008 · DOI · Paper page
  170. Purkerson-Parker, 2001, Dopamine transporter binding in the rat striatum is increased by gestational, perinatal and adolescent exposure to heptachlor, Toxicol. Sci., 64, 216, 10.1093/toxsci/64.2.216 · doi:10.1093/toxsci/64.2.216
  171. Radad, 2006, Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration, Neurochem. Int., 49, 379, 10.1016/j.neuint.2006.02.003 · DOI
  172. Ramos-Chávez, 2015, Neurological effects of inorganic arsenic exposure: altered cysteine/glutamate transport, NMDA expression and spatial memory impairment, Front. Cell. Neurosci., 9, 21, 10.3389/fncel.2015.00021 · DOI
  173. Rappold, 2011, Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3, Proc. Natl. Acad. Sci. U S A, 108, 20766, 10.1073/pnas.1115141108 · DOI
  174. Ray, 2014, Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead and mercury: strategies and challenges, Front. Genet., 5, 201, 10.3389/fgene.2014.00201 · DOI
  175. Richardson, 2014, Elevated serum pesticide levels and risk for Alzheimer disease, JAMA Neurol., 71, 284, 10.1001/jamaneurol.2013.6030 · DOI · Paper page
  176. Rodier, 1955, Manganese poisoning in Moroccan miners, Br. J. Ind. Med., 12, 21, 10.1136/oem.12.1.21 · DOI · Paper page
  177. Rybicki, 1993, Parkinson’s disease mortality and the industrial use of heavy metals in Michigan, Mov. Disord., 8, 87, 10.1002/mds.870080116 · DOI · Paper page
  178. Sakamoto, 2006, Aluminum inhibits proteolytic degradation of amyloid beta peptide by cathepsin D: a potential link between aluminum accumulation and neuritic plaque deposition, FEBS Lett., 580, 6543, 10.1016/j.febslet.2006.10.075 · DOI
  179. Salazar, 2011, Amyloid beta peptide levels increase in brain of AbetaPP Swedish mice after exposure to chlorpyrifos, Curr. Alzheimer Res., 8, 732, 10.2174/156720511797633197 · DOI
  180. Sanchez-Ramos, 1998, Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures, Exp. Neurol., 150, 263, 10.1006/exnr.1997.6770 · DOI
  181. Sandhir, 1994, Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes, Pharmacol. Toxicol., 74, 66, 10.1111/j.1600-0773.1994.tb01077.x · DOI · Paper page
  182. Schmuck, 2002, Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro, Neurotox. Res., 4, 1, 10.1080/10298420290007574 · DOI
  183. Schrag, 2002, How valid is the clinical diagnosis of Parkinson’s disease in the community?, J. Neurol. Neurosurg. Psychiatry, 73, 529, 10.1136/jnnp.73.5.529 · DOI · Paper page
  184. Sharma, 2009, Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches, J. Nanosci. Nanotechnol., 9, 5055, 10.1166/jnn.2009.gr09 · DOI · Paper page
  185. Sharma, 2012, Neurotoxicity of engineered nanoparticles from metals, CNS Neurol. Disord. Drug Targets, 11, 65, 10.2174/187152712799960817 · DOI
  186. Shen, 2014, Positive relationship between mortality from Alzheimer’s disease and soil metal concentration in mainland China, J. Alzheimers Dis., 42, 893, 10.3233/JAD-140153 · DOI
  187. Sherer, 2002, An in vitro model of Parkinson’s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage, J. Neurosci., 22, 7006, 10.1523/JNEUROSCI.22-16-07006.2002 · DOI · Paper page
  188. Sherer, 2003, Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation, Exp. Neurol., 179, 9, 10.1006/exnr.2002.8072 · DOI · Paper page
  189. Sherer, 2007, Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease, J. Neurochem., 100, 1469, 10.1111/j.1471-4159.2006.04333.x · DOI · Paper page
  190. Shin, 2003, A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer’s disease, Brain Res., 961, 139, 10.1016/s0006-8993(02)03893-3 · DOI
  191. Shin, 1994, Aluminum modifies the properties of Alzheimer’s disease PHF tau proteins in vivo and in vitro, J. Neurosci., 14, 7221, 10.1523/JNEUROSCI.14-11-07221.1994 · DOI
  192. Sian-Hulsmann, 2011, The relevance of iron in the pathogenesis of Parkinson’s disease, J. Neurochem., 118, 939, 10.1111/j.1471-4159.2010.07132.x · DOI · Paper page
  193. Singer, 1997, Tau in aluminum-induced neurofibrillary tangles, Neurotoxicology, 18, 63
  194. Smargiassi, 1998, A case-control study of occupational and environmental risk factors for Parkinson’s disease in the Emilia-Romagna region of Italy, Neurotoxicology, 19, 709
  195. Smith, 1997a, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc. Natl. Acad. Sci. U S A, 94, 9866, 10.1073/pnas.94.18.9866 · DOI · Paper page
  196. Smith, 1997b, Widespread peroxynitrite-mediated damage in Alzheimer’s disease, J. Neurosci., 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997 · DOI · Paper page
  197. Song, 2013, Mercury induced the accumulation of amyloid beta (Abeta) in PC12 cells: the role of production and degradation of abeta, Toxicol. Res., 29, 235, 10.5487/tr.2013.29.4.235 · DOI
  198. Spillantini, 1998, alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies, Proc. Natl. Acad. Sci. U S A, 95, 6469, 10.1073/pnas.95.11.6469 · DOI · Paper page
  199. Sun, 2005, Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death, J. Pharmacol. Exp. Ther., 315, 69, 10.1124/jpet.105.084632 · DOI
  200. Sun, 2012, Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer’s disease, J. Neurochem., 120, 62, 10.1111/j.1471-4159.2011.07515.x · DOI

200 of 242 shown

Cited by

See all 707

Metadata

Authors
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B.
Venue
Frontiers in Cellular Neuroscience
Publisher
Frontiers Media SA
Published
2015-04-10
Volume
9
Pages
124-124
ISSN
1662-5102 (ISSN-L)
DOI
10.3389/fncel.2015.00124
OpenAlex
W2034578928
Cited by
707
References
24
FWCI
37.02
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. https://app.cochat.ai/papers/10.3389/fncel.2015.00124
The paper
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015). Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2015.00124

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.